drugset / Trial / NCT01878474
Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 With Single, Escalating Doses in Healthy Subjects
RandomizedSingle-groupDouble-blindTreatment
Summary
The purpose of this study is to assess the safety and tolerability of single doses of TA-8995 in healthy Caucasian and Japanese volunteers.
Timeline
- Start
- 2008-03
- Primary completion
- 2009-06
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Obicetrapib | Small molecule | 5 mg | — |
| Subject | Obicetrapib | Small molecule | 10 mg | — |
| Subject | Obicetrapib | Small molecule | 25 mg | — |
| Subject | Obicetrapib | Small molecule | 50 mg | — |
| Subject | Obicetrapib | Small molecule | 100 mg | — |
| Subject | Obicetrapib | Small molecule | 150 mg | — |